Please try another search
Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson’s in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company’s lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. The company was founded in 1999 and is headquartered in Bresso, Italy.
| Name | Age | Since | Title |
|---|---|---|---|
| Luca Benatti | 62 | 1998 | Non-Executive & Independent Director |
| Fabrizio Stocchi | - | - | Member of Scientific and Clinical Advisory Board |
| Paolo Marchettini | - | - | Member of Scientific & Clinical Advisory Board |
| Richard Paul Murphy | 58 | 2002 | Chairman of the Board of Statutory Auditors |
| Emilio Perucca | - | - | Member of Scientific & Clinical Advisory Board |
| Ze’ ev Seltzer | - | - | Member of Scientific & Clinical Advisory Board |
| Stefan Weber | 57 | 2005 | CEO & Executive Director |
| Patrick J. Langlois | 77 | 2008 | Independent Non-Executive Director |
| Abraham Lieberman | - | - | Member of Scientific Advisory Board |
| Marco Onofrj | - | - | Member of Scientific Advisory Board |
| William Langston | - | - | Member of Scientific Advisory Board |
| Lucio Giulio Ricci | 56 | 2002 | Member of the Board of Statutory Auditors |
| Margarita I. Chavez | - | 2023 | Independent Director |
| Gillian Dines | - | 2023 | Independent Non-Executive Director |
| Alessandro Isacco | - | 2024 | Member of the Board of Statutory Auditor |
| Christopher J. Martin | 66 | 2025 | Independent Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review